Ella Fitszimmons
Sep 10, 2008

Xian Janssen shifts two brands to Bates141

BEIJING - Bates141 has secured the creative duties for two of Johnson & Johnson subsidiary Xian Janssen Pharmaceutical's over-the-counter products, following a pitch contested by two other agencies.

Xian Janssen shifts two brands to Bates141
DMG was the incumbent for Motilium, which has a reported media spend of US$30 million, though it could not be confirmed whether it attempted to defend the account.

Motilium (a stomach motility drug) is currently the most successful OTC medication across categories in China. The second brand, Mylanta, is a new antacid.

Source:
Campaign China

Related Articles

Just Published

22 hours ago

Women to Watch 2024: Margaret Key, MSL

As a regional leader, Key has been a driving force behind transforming Publicis Groupe's comms offerings by influencing talent, services, and business growth in APAC.

23 hours ago

Bonds taps Robert Irwin to show how wild comfort ...

Australia’s most beloved animal-lover trades khakis for cotton to front the new campaign, introducing American audiences to undies that hold up under pressure—snakes, crocs and all.

1 day ago

Common Interest acquires Amplify to 'empower ...

The previously independent brand experience agency has offices in London, LA, Paris, New York and Sydney.